Huitema ADR - Search Results

1

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.

van Geel RMJM, van Brummelen EMJ, Eskens FALM, Huijberts SCFA, de Vos FYFL, Lolkema MPJK, Devriese LA, Opdam FL, Marchetti S, Steeghs N, Monkhorst K, Thijssen B, Rosing H, Huitema ADR, Beijnen JH, Bernards R, Schellens JHM. van Geel RMJM, et al. Among authors: huitema adr. Br J Cancer. 2020 Apr;122(8):1166-1174. doi: 10.1038/s41416-020-0776-z. Epub 2020 Mar 9. Br J Cancer. 2020. PMID: 32147669 Free PMC article. Clinical Trial.

2

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin.

Huitema AD, Spaander M, Mathĵt RA, Tibben MM, Holtkamp MJ, Beijnen JH, Rodenhuis S. Huitema AD, et al. Ann Oncol. 2002 Mar;13(3):374-84. doi: 10.1093/annonc/mdf052. Ann Oncol. 2002. PMID: 11996467 Free article.

3

Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals.

de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Beijnen JH. de Maat MM, et al. Br J Clin Pharmacol. 2002 Oct;54(4):378-85. doi: 10.1046/j.1365-2125.2002.01657.x. Br J Clin Pharmacol. 2002. PMID: 12392585 Free PMC article. Clinical Trial.

4

Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.

de Jonge ME, Mathôt RA, Dalesio O, Huitema AD, Rodenhuis S, Beijnen JH. de Jonge ME, et al. Bone Marrow Transplant. 2002 Nov;30(9):593-7. doi: 10.1038/sj.bmt.1703695. Bone Marrow Transplant. 2002. PMID: 12407434

5

The boosting of didanosine by allopurinol permits a halving of the didanosine dosage.

Boelaert JR, Dom GM, Huitema AD, Beijnen JH, Lange JM. Boelaert JR, et al. AIDS. 2002 Nov 8;16(16):2221-3. doi: 10.1097/00002030-200211080-00016. AIDS. 2002. PMID: 12409745 No abstract available.

6

Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.

Crommentuyn KM, Rosing H, Nan-Offeringa LG, Hillebrand MJ, Huitema AD, Beijnen JH. Crommentuyn KM, et al. J Mass Spectrom. 2003 Feb;38(2):157-66. doi: 10.1002/jms.425. J Mass Spectrom. 2003. PMID: 12577282

7

Drug interactions between antiretroviral drugs and comedicated agents.

de Maat MM, Ekhart GC, Huitema AD, Koks CH, Mulder JW, Beijnen JH. de Maat MM, et al. Clin Pharmacokinet. 2003;42(3):223-82. doi: 10.2165/00003088-200342030-00002. Clin Pharmacokinet. 2003. PMID: 12603174 Review.

8

Population pharmacokinetics of itraconazole in Thai HIV-1-infected persons.

Koks CH, Huitema AD, Kroon ED, Chuenyam T, Sparidans RW, Lange JM, Beijnen JH. Koks CH, et al. Ther Drug Monit. 2003 Apr;25(2):229-33. doi: 10.1097/00007691-200304000-00014. Ther Drug Monit. 2003. PMID: 12657919 Clinical Trial.

9

Subtherapeutic antiretroviral plasma concentrations in routine clinical outpatient HIV care.

de Maat MM, Huitema AD, Mulder JW, Meenhorst PL, van Gorp EC, Mairuhu AT, Beijnen JH. de Maat MM, et al. Ther Drug Monit. 2003 Jun;25(3):367-73. doi: 10.1097/00007691-200306000-00018. Ther Drug Monit. 2003. PMID: 12766566

10

Low nevirapine plasma concentrations predict virological failure in an unselected HIV-1-infected population.

de Vries-Sluijs TE, Dieleman JP, Arts D, Huitema AD, Beijnen JH, Schutten M, van der Ende ME. de Vries-Sluijs TE, et al. Clin Pharmacokinet. 2003;42(6):599-605. doi: 10.2165/00003088-200342060-00009. Clin Pharmacokinet. 2003. PMID: 12793844

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

540 results

Search Page

Filters